Ginkgo Bioworks Holdings (DNA) FCF Margin (2020 - 2026)

Ginkgo Bioworks Holdings has reported FCF Margin for 7 years, with the latest figure at 248.36% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin fell 9366.0% year-over-year to 248.36%; the trailing twelve-month figure through Mar 2026 stood at 118.85% (up 3305.0% YoY), and the FY2025 full-year result was 105.04%, up 6327.0% from the prior year.
• FCF Margin for Q1 2026 stood at 248.36%, down from 142.78% in the prior quarter.
• The five-year high for FCF Margin was 13.94% in Q1 2022, with the low at 252.92% in Q1 2024.
• Historically, FCF Margin has averaged 132.87% across 5 years, with a median of 136.34% in 2023.
• Annual changes were most pronounced in 2022 — FCF Margin soared 14495 bps — and 2023, when it slumped 12239 bps.
• Ginkgo Bioworks Holdings' FCF Margin stood at 149.36% in 2022, then retreated by 18 bps to 176.31% in 2023, then grew by 27 bps to 128.05% in 2024, then slipped by 12 bps to 142.78% in 2025, then sank by 74 bps to 248.36% in 2026.
• The last three FCF Margin figures came in at 248.36% (Q1 2026), 142.78% (Q4 2025), and 81.38% (Q3 2025), per Business Quant data.